InvestorsHub Logo
Followers 5
Posts 601
Boards Moderated 0
Alias Born 06/08/2009

Re: None

Friday, 05/10/2024 9:44:21 AM

Friday, May 10, 2024 9:44:21 AM

Post# of 8621
Gotta love how these reporters ( AI??, lol) use their terminology for price change’s :

These analysts made changes to their price targets on Revance Therapeutics (RVNC.NaE) following earnings announcement.
• Needham ‘cut’ the price target on Revance Therapeutics (RVNC.NaE) from $18 to $12.
Needham analyst Serge Belanger maintained a Buy rating.(~30% cut)
• Mizuho ‘slashed’ the price target on Revance
Therapeutics (RVNC.NaE) from $9 to $8( ~10% slash)…
Mizuho analyst Vamil Divan maintained a
Neutral rating.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News